Needham downgraded Clearside Biomedical (CLSD) to Hold from Buy with a $3 price target
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLSD:
- Clearside Biomedical downgraded to Hold from Buy at JonesResearch
- Hold Rating for Clearside Biomedical Amid Strategic Uncertainty and Financial Constraints
- Clearside Biomedical Explores Strategic Alternatives Amid Economic Challenges
- Clearside Biomedical transitions all employees to consulting roles
- Clearside Biomedical to explore strategic alternatives to advance SCS platform